Edmond R. White

Synergy between PI3K/Akt and Raf/MEK/ERK Pathways in IGF-1R Mediated Cell Cycle Progression and Prevention of Apoptosis in Hematopoietic Cells

J. McCubrey, L. Steelman, J. G. Shelton, 2004, Cell cycle.

Ability of the Activated PI3K/Akt Oncoproteins to Synergize with MEK1 and Induce Cell Cycle Progression and Abrogate the Cytokine-Dependence of Hematopoietic Cells

J. McCubrey, L. Steelman, J. G. Shelton, 2004, Cell cycle.

Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells

Stephen L. Abrams, F. E. Bertrand, J. McCubrey, 2006, Leukemia.